Replies to post #2343 on Enanta Pharmaceuticals Inc (ENTA)

[biocqr]

Since Omicron variant BQ.1.1 is resistant to all treatments and is now >57% of all cases in the U.S. and there's no assay listed on slide 19 for BQ.1.1 is that something to be concerned about?

New COVID Subvariant Resistant to All Therapeutic Antibodies

Omicron variant BQ.1.1 found to be resistant to all monoclonal antibody treatments

[DewDiligence]

ENTA’s new corporate slide set—(1/6/23):

https://ir.enanta.com/static-files/0b9a9564-339c-4501-8c98-eab636846bf4